mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.006 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.006 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.006 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.007 |